🎉 M&A multiples are live!
Check it out!

Ansell Valuation Multiples

Discover revenue and EBITDA valuation multiples for Ansell and similar public comparables like Gerresheimer, Fresenius, and Fresenius Medical Care.

Ansell Overview

About Ansell

Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.


Founded

1920

HQ

Australia
Employees

16.0K+

Website

ansell.com

Financials

LTM Revenue $3.0B

LTM EBITDA $501M

EV

$3.6B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Ansell Financials

Ansell has a last 12-month revenue of $3.0B and a last 12-month EBITDA of $501M.

In the most recent fiscal year, Ansell achieved revenue of $1.0B and an EBITDA of $126M.

Ansell expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Ansell valuation multiples based on analyst estimates

Ansell P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $1.0B $1.0B XXX XXX XXX
Gross Profit $413M $383M XXX XXX XXX
Gross Margin 40% 38% XXX XXX XXX
EBITDA $171M $126M XXX XXX XXX
EBITDA Margin 17% 12% XXX XXX XXX
Net Profit $98.5M $92.0M XXX XXX XXX
Net Margin 10% 9% XXX XXX XXX
Net Debt $137M $154M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Ansell Stock Performance

As of March 13, 2025, Ansell's stock price is AUD 34 (or $21).

Ansell has current market cap of AUD 4.9B (or $3.0B), and EV of AUD 5.8B (or $3.6B).

See Ansell trading valuation data

Ansell Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$3.6B $3.0B XXX XXX XXX XXX $1.14

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Ansell Valuation Multiples

As of March 13, 2025, Ansell has market cap of $3.0B and EV of $3.6B.

Ansell's trades at 1.9x LTM EV/Revenue multiple, and 11.5x LTM EBITDA.

Analysts estimate Ansell's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Ansell and 10K+ public comps

Ansell Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $3.6B XXX XXX XXX
EV/Revenue 2.4x XXX XXX XXX
EV/EBITDA 15.4x XXX XXX XXX
P/E 27.1x XXX XXX XXX
P/E/Growth 0.8x XXX XXX XXX
EV/FCF 24.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Ansell Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Ansell Valuation Multiples

Ansell's NTM/LTM revenue growth is 11%

Ansell's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $22K for the same period.

Over next 12 months, Ansell's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Ansell's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Ansell and other 10K+ public comps

Ansell Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -2% XXX XXX XXX XXX
EBITDA Margin 15% XXX XXX XXX XXX
EBITDA Growth -26% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 27% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $22K XXX XXX XXX XXX
S&M Expenses to Revenue 31% XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 35% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Ansell Public Comps

See public comps and valuation multiples for Medical Supplies comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Polymed XXX XXX XXX XXX XXX XXX
Schott Pharma XXX XXX XXX XXX XXX XXX
Fresenius Medical Care XXX XXX XXX XXX XXX XXX
Fresenius XXX XXX XXX XXX XXX XXX
Gerresheimer XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Ansell M&A and Investment Activity

Ansell acquired  XXX companies to date.

Last acquisition by Ansell was  XXXXXXXX, XXXXX XXXXX XXXXXX . Ansell acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Ansell

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Ansell

When was Ansell founded? Ansell was founded in 1920.
Where is Ansell headquartered? Ansell is headquartered in Australia.
How many employees does Ansell have? As of today, Ansell has 16.0K+ employees.
Who is the CEO of Ansell? Ansell's CEO is Mr. Neil I. Salmon.
Is Ansell publicy listed? Yes, Ansell is a public company listed on ASX.
What is the stock symbol of Ansell? Ansell trades under ANN ticker.
When did Ansell go public? Ansell went public in 1985.
Who are competitors of Ansell? Similar companies to Ansell include e.g. Polymed, Schott Pharma, Fresenius Medical Care, Fresenius.
What is the current market cap of Ansell? Ansell's current market cap is $3.0B
What is the current revenue of Ansell? Ansell's last 12-month revenue is $3.0B.
What is the current EBITDA of Ansell? Ansell's last 12-month EBITDA is $501M.
What is the current EV/Revenue multiple of Ansell? Current revenue multiple of Ansell is 1.9x.
What is the current EV/EBITDA multiple of Ansell? Current EBITDA multiple of Ansell is 11.5x.
What is the current revenue growth of Ansell? Ansell revenue growth between 2023 and 2024 was -2%.
Is Ansell profitable? Yes, Ansell is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.